INVEGA TRINZA (Janssen Pharmaceuticals, Inc)


Welcome to the PulseAid listing for the INVEGA TRINZA drug offered from Janssen Pharmaceuticals, Inc. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Pharmaceuticals, Inc
NON-PROPRIETARY NAME: paliperidone palmitate
SUBSTANCE NAME: PALIPERIDONE PALMITATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-05-19
END MARKETING DATE: 0000-00-00


INVEGA TRINZA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINVEGA TRINZA from Janssen Pharmaceuticals, Inc
LABELER NAME: Janssen Pharmaceuticals, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 273(mg/.875mL)
START MARKETING DATE: 2015-05-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50458-606_cee057fd-9f3d-43d0-8779-0230b0d187c1
PRODUCT NDC: 50458-606
APPLICATION NUMBER: NDA207946

Other PALIPERIDONE PALMITATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Pharmaceuticals, IncINVEGA TRINZA
Janssen Pharmaceuticals, Inc.INVEGA SUSTENNA